Lansforsakringar Fondforvaltning AB (publ)
Position in ABT — Abbott Laboratories
CIK 2059323
Stockholm, V7
Position in ABT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$48,466,774
-$9,048,138 QoQ
Shares Held
534,128
-4.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#220
of 2,958 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $194,046,717 across 9 Medical Devices names. ABT ranks #2 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,581,108 | $67,481,689 | |
| 2 | ABT |
Abbott Laboratories
This page
|
534,128 | $48,466,774 | |
| 3 | SYK |
Stryker Corp
|
81,022 | $25,508,966 | |
| 4 | MDT |
Medtronic plc
|
325,753 | $25,483,657 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
133,240 | $8,528,692 | |
| 6 | DXCM |
Dexcom Inc
|
91,840 | $6,185,424 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
62,564 | $5,386,134 | |
| 8 | STE |
STERIS plc
|
21,990 | $4,630,434 |
All Filings in ABT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,466,774 | 534,128 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $57,514,912 | 560,192 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $70,341,063 | 561,426 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $73,156,956 | 546,192 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $72,679,663 | 534,370 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $74,431,904 | 561,115 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $65,392,849 | 578,135 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||